History
2025: Participation in the medical cartel for 277 million rubles
On December 29, 2025, the Federal Antimonopoly Service (FAS) of Russia opened a case of possible collusion at tenders for the supply of medical devices and consumables to healthcare institutions in Moscow. Signs of an agreement limiting competition were identified in 114 procurement procedures totaling about 277 million rubles.
According to the press service of the FAS RF, the identification of a possible violation was carried out using the state information system "Antikartel," which analyzes the behavior of the bidders.
The defendants in the case were the companies Catonica, Vector-M, Transformation, Remedix and Medvet, as well as two individual entrepreneurs. If violations are confirmed, participants may be given administrative fines.
Purchases were carried out for medical organizations subordinate to the Moscow Department of Health. The customers were the city clinical hospitals named after S. S. Yudin and No. 29 named after N. E. Bauman, Psychiatric Clinical Hospital No. 1 named after N.A. Alekseev, Hospital of War Veterans No. 3 and Endocrinological Dispensary. We are talking about the supply of laboratory equipment, including biochemical, hematological and coagulometric analyzers, as well as reagents and consumables.
According to the SPARK-Interfax system, the companies involved crossed paths with participation in public procurement. The beneficiary of three organizations - Katonika LLC, Vector-M LLC and Transformation LLC - is Tatyana Anokhina. The general director of Katonika LLC is Irina Karpova, Vector-M LLC - Tatyana Anokhina, Transformation LLC - Tatyana Dedova. The revenue of these companies at the end of 2024 amounted to: Katonika - 45.8 million rubles, Vector-M - 89.4 million rubles, Transformation - 170.9 million rubles.
The director and owner of Remedix LLC is Alina Yerpuleva, the company's revenue for 2024 is 150.7 million rubles. Anna Filatova is the director of Medvet LLC, Maria Stukalova is the beneficiary, the company's revenue is 134.3 million rubles.[1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |